First Time Loading...

Geron Corp
NASDAQ:GERN

Watchlist Manager
Geron Corp Logo
Geron Corp
NASDAQ:GERN
Watchlist
Price: 3.845 USD -0.65%
Updated: May 8, 2024

Geron Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Geron Corp
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Geron Corp
NASDAQ:GERN
Revenue
$517k
CAGR 3-Years
15%
CAGR 5-Years
-9%
CAGR 10-Years
-6%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$29.5B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
19%

See Also

What is Geron Corp's Revenue?
Revenue
517k USD

Based on the financial report for Mar 31, 2024, Geron Corp's Revenue amounts to 517k USD.

What is Geron Corp's Revenue growth rate?
Revenue CAGR 10Y
-6%

Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Geron Corp have been 15% over the past three years , -9% over the past five years , and -6% over the past ten years .